These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6661511)

  • 21. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the pharmacokinetics of 16-acetyl-gitoxin and its bioavailability from pengitoxin-containing tablet formulations.
    Haustein KO
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):357-64. PubMed ID: 3772737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.
    Breimer DD; de Boer AG
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):169-78. PubMed ID: 9299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation.
    Kakuda TN; Leopold L; Timmers M; Van De Casteele T; Hillewaert V; Tomaka FL; Hoetelmans RM
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):805-16. PubMed ID: 25109510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics and bioavailability of cilazapril in normal man.
    Williams PE; Brown AN; Rajaguru S; Francis RJ; Walters GE; McEwen J; Durnin C
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):181S-188S. PubMed ID: 2527531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absolute bioavailability of cefixime in man.
    Faulkner RD; Fernandez P; Lawrence G; Sia LL; Falkowski AJ; Weiss AI; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects.
    Dominiak P; Grevel J; Abisch E; Grobecker H; Dennler HJ; Welzel D
    Eur J Clin Pharmacol; 1988; 35(1):53-7. PubMed ID: 3146506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
    Sun H; Ting L; Machineni S; Praestgaard J; Kuemmell A; Stein DS; Sunkara G; Kovacs SJ; Villano S; Tanaka SK
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7431-7435. PubMed ID: 27736760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of intramuscularly administered tenoxicam.
    Stebler T; Guentert TW
    Biopharm Drug Dispos; 1993 Aug; 14(6):483-90. PubMed ID: 8218966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of cotinine after oral and intravenous administration to man.
    De Schepper PJ; Van Hecken A; Daenens P; Van Rossum JM
    Eur J Clin Pharmacol; 1987; 31(5):583-8. PubMed ID: 3830243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of labetalol in healthy volunteers.
    Kanto J; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):41-4. PubMed ID: 7203731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration.
    Appelbaum SJ; Mayersohn M; Dorr RT; Perrier D
    Cancer Chemother Pharmacol; 1982; 8(1):93-8. PubMed ID: 7094203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative bioavailability of a commercial propranolol hydrochloride tablet in man.
    Roscoe R; Cooper J; Wilson TW; Joshi NN; Midha KK
    Biopharm Drug Dispos; 1982; 3(2):105-14. PubMed ID: 7104460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flecainide: single and multiple oral dose kinetics, absolute bioavailability and effect of food and antacid in man.
    Tjandra-Maga TB; Verbesselt R; Van Hecken A; Mullie A; De Schepper PJ
    Br J Clin Pharmacol; 1986 Sep; 22(3):309-16. PubMed ID: 3094570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative bioavailability and safety profile of gefitinib administered as a tablet or as a dispersion preparation via drink or nasogastric tube: results of a randomized, open-label, three-period crossover study in healthy volunteers.
    Cantarini MV; McFarquhar T; Smith RP; Bailey C; Marshall AL
    Clin Ther; 2004 Oct; 26(10):1630-6. PubMed ID: 15598479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man.
    Martin W; Koselowske G; Töberich H; Kerkmann T; Mangold B; Augustin J
    Biopharm Drug Dispos; 1990 Apr; 11(3):265-78. PubMed ID: 2109643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.
    Hussain MA; Aungst BJ; Lam G; Shefter E
    Biopharm Drug Dispos; 1987; 8(5):497-505. PubMed ID: 3663885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
    Huupponen R; Paija O; Salonen M; Björklund H; Rouru J; Anttila M
    Drugs R D; 2003; 4(6):339-45. PubMed ID: 14584962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.